BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26873165)

  • 1. Use of Statins to Augment Progenitor Cell Function in Preclinical and Clinical Studies of Regenerative Therapy: a Systematic Review.
    Park A; Barrera-Ramirez J; Ranasinghe I; Pilon S; Sy R; Fergusson D; Allan DS
    Stem Cell Rev Rep; 2016 Jun; 12(3):327-39. PubMed ID: 26873165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of statins on circulating endothelial progenitor cells in humans: a systematic review.
    Hibbert B; Simard T; Ramirez FD; Pourdjabbar A; Raizman JE; Maze R; Wilson KR; Hawken S; OʼBrien ER
    J Cardiovasc Pharmacol; 2013 Nov; 62(5):491-6. PubMed ID: 23933855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin and rosuvastatin mobilize Endothelial Progenitor Cells but do not prevent their acute decrease during systemic inflammation.
    Spiel AO; Mayr FB; Leitner JM; Firbas C; Sieghart W; Jilma B
    Thromb Res; 2008; 123(1):108-13. PubMed ID: 18433844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of HMG-CoA reductase inhibitor on vascular progenitor cells.
    Kusuyama T; Omura T; Nishiya D; Enomoto S; Matsumoto R; Murata T; Takeuchi K; Yoshikawa J; Yoshiyama M
    J Pharmacol Sci; 2006 Aug; 101(4):344-9. PubMed ID: 16891763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of High Dose Statin Pretreatment on Endothelial Progenitor Cells After Percutaneous Coronary Intervention (HIPOCRATES Study).
    Eisen A; Leshem-Lev D; Yavin H; Orvin K; Mager A; Rechavia E; Bental T; Dadush O; Battler A; Kornowski R; Lev EI
    Cardiovasc Drugs Ther; 2015 Apr; 29(2):129-35. PubMed ID: 25712416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins, HMG-CoA Reductase Inhibitors, Improve Neovascularization by Increasing the Expression Density of CXCR4 in Endothelial Progenitor Cells.
    Chiang KH; Cheng WL; Shih CM; Lin YW; Tsao NW; Kao YT; Lin CT; Wu SC; Huang CY; Lin FY
    PLoS One; 2015; 10(8):e0136405. PubMed ID: 26309120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of prior chronic statin therapy and high-intensity statin therapy at discharge on circulating endothelial progenitor cell levels in patients with acute myocardial infarction: a prospective observational study.
    António N; Fernandes R; Soares A; Soares F; Lopes A; Carvalheiro T; Paiva A; Pêgo GM; Providência LA; Gonçalves L; Ribeiro CF
    Eur J Clin Pharmacol; 2014 Oct; 70(10):1181-93. PubMed ID: 25048407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease.
    Vasa M; Fichtlscherer S; Adler K; Aicher A; Martin H; Zeiher AM; Dimmeler S
    Circulation; 2001 Jun; 103(24):2885-90. PubMed ID: 11413075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined transplantation of mesenchymal stem cells and endothelial progenitor cells for tissue engineering: a systematic review and meta-analysis.
    Sun K; Zhou Z; Ju X; Zhou Y; Lan J; Chen D; Chen H; Liu M; Pang L
    Stem Cell Res Ther; 2016 Oct; 7(1):151. PubMed ID: 27724974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors.
    Deschaseaux F; Selmani Z; Falcoz PE; Mersin N; Meneveau N; Penfornis A; Kleinclauss C; Chocron S; Etievent JP; Tiberghien P; Kantelip JP; Davani S
    Eur J Pharmacol; 2007 May; 562(1-2):111-8. PubMed ID: 17320859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway.
    Dimmeler S; Aicher A; Vasa M; Mildner-Rihm C; Adler K; Tiemann M; Rütten H; Fichtlscherer S; Martin H; Zeiher AM
    J Clin Invest; 2001 Aug; 108(3):391-7. PubMed ID: 11489932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes.
    Assmus B; Urbich C; Aicher A; Hofmann WK; Haendeler J; Rössig L; Spyridopoulos I; Zeiher AM; Dimmeler S
    Circ Res; 2003 May; 92(9):1049-55. PubMed ID: 12676819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy.
    Schmidt-Lucke C; Fichtlscherer S; Rössig L; Kämper U; Dimmeler S
    Atherosclerosis; 2010 Jul; 211(1):249-54. PubMed ID: 20211468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins Therapy is Associated with Increased Populations of Early Endothelial Progenitor (CD133+/VEGFR2+) and Endothelial (CD34-/CD133- /VEGFR2+) Cells in Patients with Acute Ischemic Stroke.
    Golab-Janowska M; Paczkowska E; Machalinski B; Meller A; Kotlega D; Safranow K; Wankowicz P; Nowacki P
    Curr Neurovasc Res; 2018; 15(2):120-128. PubMed ID: 29886830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells.
    Thum T; Fraccarollo D; Galuppo P; Tsikas D; Frantz S; Ertl G; Bauersachs J
    Cardiovasc Res; 2006 Apr; 70(1):50-60. PubMed ID: 16480696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells.
    Llevadot J; Murasawa S; Kureishi Y; Uchida S; Masuda H; Kawamoto A; Walsh K; Isner JM; Asahara T
    J Clin Invest; 2001 Aug; 108(3):399-405. PubMed ID: 11489933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins for Smith-Lemli-Opitz syndrome.
    Ballout RA; Livinski A; Fu YP; Steiner RD; Remaley AT
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013521. PubMed ID: 36373961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells.
    Spyridopoulos I; Haendeler J; Urbich C; Brummendorf TH; Oh H; Schneider MD; Zeiher AM; Dimmeler S
    Circulation; 2004 Nov; 110(19):3136-42. PubMed ID: 15520325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of bone morphogenetic protein 2 in the crosstalk between endothelial progenitor cells and mesenchymal stem cells.
    Raida M; Heymann AC; Günther C; Niederwieser D
    Int J Mol Med; 2006 Oct; 18(4):735-9. PubMed ID: 16964430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment.
    Hristov M; Fach C; Becker C; Heussen N; Liehn EA; Blindt R; Hanrath P; Weber C
    Atherosclerosis; 2007 Jun; 192(2):413-20. PubMed ID: 16837000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.